- According to Gary Robinson

Quantum computing and AI are massive tailwinds for healthcare research and San Diego’s Illumina leads the way. Its machines have lowered the cost of sequencing a human genome from $10 million in 2007 to $1,000 and are changing how cancer screening and research is done. “We are moving from a world where decisions on which drugs to give a patient were primarily made on educated guesses to one where they are made on the basis of data,” says Gary Robinson, a portfolio manager at $260-billion-in-assets Baillie Gifford. A recent dip in sales growth caused Illumina shares to drop by 25% from record highs, but Robinson shrugs at the volatility. “The healthcare sector is large and inefficien­t and therefore it is ripe for change,” he says, “Illumina is the primary beneficiar­y.”

 ??  ??

Newspapers in English

Newspapers from United States